Skip to main content
editorial
. 2023 May 22;12(3):435–439. doi: 10.21037/hbsn-23-203

Figure 1.

Figure 1

IMbrave050 study design. HCC, hepatocellular carcinoma; ECOG, Eastern Cooperative Oncology Group; TACE, transarterial chemoembolization.